Clinical tests for the presence or absence of estrogen receptor (ER) are routinely run to facilitate the choice of therapy, with human breast cancer cells currently being categorized into three broad classes based on the level of ER presented in the cells and on the functional state of ER [4]. The gene discussed is ESR1; the disease is breast carcinoma.